GYRE Gyre Therapeutics Inc notches 102 percent year over year revenue growth shares climb despite modest EPS miss ChargePoint CHPT Stock Intraday Analysis Near Highs 20260418 Following the strong quarterly performance management raised its 2026 outlook Federal FRT Stock Schedule 13 Breakout Watch 20260418 Dollar General Corporation DG Fiscal Q1 2027 Earnings Preview NearTerm Bearish Risks Amid Leadership Transition BACK BoA Pref HH conventional quarterly earnings metrics do not apply to its 5875 noncumulative preferred stock series How Liberty FWONA earnings power stacks up historically Q4 2025 Below Expectations How Takeda TAK pricing offsets input costs Q1 2026 EPS Tops Views Greeces Budget Surplus Surges Past 5 Billion in First Quarter Doubling Fiscal Target Credo CRDO Q1 2026 Earnings Beat Revenue NA EPS 107 UK Government Cracks Down on BotDriven Driving Test Resale Market DLF Reports Marginal Decline in Q4 Profit as Revenue Drops 42 Board Recommends Rs 8 Dividend Spotify and Universal Music Group Reach Licensing Deal for AIGenerated Remixes Himalayan Ashram Tourism Drives Economic Shift in Northern Indias Foothills CBRS Spectrum Drives US Manufacturing Transformation Industry Data Highlights SP 500 Edges Higher as Healthcare and Tech Lead Communication Services Slips Spains Youth Rent Burden Hits 987 of Pay as Emancipation Rate Falls to Record Low Rigetti Computing Shares Surge on 100 Million Government Funding Announcement NXE Q1 2026 Earnings EPS Misses Estimates Significantly as Stock Gains on LongTerm Outlook Evolution Petroleum EPM Q1 2026 Earnings Steep Earnings Miss Sends Stock Lower Carlyle Group Q1 2026 Earnings Missed EPS Expectations Amid Volatile Markets TV Q1 2026 Earnings Massive EPS Surprise Fuels Investor Optimism Kenon Holdings Q2 2025 Earnings Modest Profit Amid Quiet Quarter GXAI Q1 2026 Earnings EPS Misses Estimates as AI Development Continues Without Revenue Akari Therapeutics AKTX Plunges 126 Amid Heightened Biotech Volatility Limoneira Co LMNR Shows Modest Gains Amid Consolidation Near Resistance Protagonist Therapeutics PTGX Hovering Near Resistance After Modest Pullback Eshallgo Inc EHGO Surges 17 Strong Momentum Breaks Above Key Resistance Rezolute Inc RZLT Slides Amid Sector Pressure Key Levels to Watch Tony Blairs Economic Diagnosis for UK Gains Traction but AI Prescription Draws Skepticism DECK Q1 2026 Earnings EPS Surprises 13 Above Estimates as Footwear Momentum Persists Acrivon Therapeutics ACRV Holds Steady Near Key Support Levels AutoZone AZO Plunges 1167 Key Support and Resistance Levels in Focus Par Pacific Holdings PARR Holds Steady Near Support as Trading Volume Signals Caution BDCIW Warrants Hold Steady at 045 as Support and Resistance Levels Define Trading Range ClearPoint Neuro CLPT Slips 222 as NearTerm Resistance Holds at 1201 Eaton Vance EXG Holds Steady Near 936 as Dividend Yield Attracts Income Seekers Axsome Therapeutics AXSM Edges Lower Maintains Posture Above NearTerm Support Catalyst Bancorp Holds Steady Near Support as Consolidation Continues